Avid Bioservices, Inc. (NASDAQ:CDMO) Q1 2021 Earnings Conference Call September 1, 2020 4:30 PM ET Company Participants Tim Brons - Investor Relations Nick Green - President and CEO Dan Hart - Chief Financial Officer Timothy Compton - Chief Commercial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Jacob Johnson - Stephens Operator Good day, ladies and gentlemen, and welcome to the Avid Bioservices First Quarter Fiscal 2021 Financial Results Conference Call. At this time, all participants ar ...

Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 par value per share CDMO The NASDAQ Stock Market LLC 10.50% Series E Convertible Preferred Stock, $0.001 par value per share CDMOP The NASDAQ Stock Market LLC Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________ FORM 10-Q _______________________________ ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 193 ...

Avid Bioservices, Inc. (NASDAQ:CDMO) Q4 2020 Earnings Conference Call June 30, 2020 4:30 PM ET Company Participants Tim Brons - IR Richard Hancock - Interim President and CEO Daniel Hart - CFO Timothy Compton - Chief Commercial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Joe Pantginis - H.C. Wainwright Jacob Johnson - Stephens Operator Good day, ladies and gentlemen and welcome to the Avid Bioservices' Fourth Quarter and Year-End 2020 Financial Results Conference Call. At t ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 par value per share CDMO The NASDAQ Stock Market LLC 10.50% Series E Convertible Preferred Stock, $0.001 par value per share CDMOP The NASDAQ Stock Market LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________ FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended Apr ...

Avid Bioservices, Inc. (NASDAQ:CDMO) Q3 2020 Earnings Conference Call March 10, 2020 4:30 PM ET Company Participants Tim Brons - Vida Strategic Partners Richard Hancock - Interim President, CEO & Director Daniel Hart - CFO Timothy Compton - Chief Commercial Officer Conference Call Participants Matthew Hewitt - Craig-Hallum Capital Group Jacob Johnson - Stephens Inc. Paul Knight - Janney Montgomery Scott Joseph Munda - First Analysis Operator Good day, ladies and gentlemen, and welcome to the Avid Bioservic ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 par value per share CDMO The NASDAQ Stock Market LLC 10.50% Series E Convertible Preferred Stock, $0.001 par value per share CDMOP The NASDAQ Stock Market LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-Q ______________________________ ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ...

Avid Bioservices, Inc. (NASDAQ:CDMO) Q2 2020 Earnings Conference Call December 9, 2019 4:30 PM ET Company Participants Rick Hancock - Interim President and CEO Dan Hart - CFO Tracy Kinjerski - VP of Business Operations Tim Brons - IR Conference Call Participants Joseph Pantginis - H.C. Wainwright Matt Hewitt - Craig-Hallum Capital Jacob Johnson - Stephens Inc. Operator Good day, ladies and gentlemen, and welcome to the Avid Bioservices Second Quarter 2020 Financial Results Conference Call. At this time, all ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 par value per share CDMO The NASDAQ Stock Market LLC 10.50% Series E Convertible Preferred Stock, $0.001 par value per share CDMOP The NASDAQ Stock Market LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2019 or o TRANSITIO ...

Avid Bioservices, Inc. (NASDAQ:CDMO) Q1 2020 Earnings Conference Call September 5, 2019 4:30 PM ET Company Participants Tim Brons - IR Rick Hancock - Interim President & CEO Dan Hart - CFO Tracy Kinjerski - VP of Business Operations Conference Call Participants Paul Knight - Janney Montgomery Steve Schwartz - First Analyst Operator Good day, ladies and gentlemen, and welcome to the Avid Bioservices First Quarter 2020 Financial Results Conference Call. [Operator Instructions] I would now like to hand the con ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ | --- | |---------------------------------------------------------------------------------------------------| | | | | | Commission file n ...